Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › H3 receptor antagonist for use in the treatment of alzheimer's disease

H3 receptor antagonist for use in the treatment of alzheimer's disease

US Patent 9789102 · Granted Oct 17, 2017

Estimated economic value: $7,245,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Promulgating exchange of information for an extraction rights market in a ground2022
Systems and methods for administering an extraction rights market in a groundwat2020
Use of 4-cyclopropylmethoxy-N-(3,5-dichloro-1-oxido-4-pyridin-4-yl)-5-(methoxy)p2016
Use of 4 cyclopropylmethoxy-N-(3,5 dichloro-1 oxido-pyridin-4 yl)-5-(methoxy)pyr2013
6-pyrimidinyl-pyrimid-4-one derivative2013
Antibodies specific of the β-amyloid peptides and their uses as diagnostic agent2013
Laminated magnetic cores2012
6-pyrimidinyl-pyrimid-4-one derivative2012
Transgenic animals exhibiting major disorders related to Alzheimer's disease2010
Leakage current protection device2010
Use of aminoindazole derivatives for the inhibition of tau phosphorylation2009
Aminoindazole derivatives as medicaments and pharmaceutical compositions includi2009